Could a tuberculosis epidemic occur in London as it did in New York? by Hayward, A. C. & Coker, R. J.
12 12 12 12 12 Emerging Infectious Diseases Vol. 6, No. 1, January–February 2000
Perspectives Perspectives Perspectives Perspectives Perspectives
Worldwide, tuberculosis (TB) kills more
people than any other infection (1). Prevalence of
the disease has been increasing in many
countries since the mid-1980s, and more people
are ill with TB now than at any other time in
history (1). Although most cases occur in the
developing world, some major urban areas in
industrialized countries have also had a
resurgence of the disease (1).
In the late 1980s and early 1990s, New York
City had a major epidemic of TB, with rates
tripling in 15 years and outbreaks of multidrug-
resistant TB in many hospitals. Massive
reinvestment in TB services to control the
epidemic (2,3) resulted in a 59% decrease in
cases, from a peak of >3,700 in 1992 to <1,000 in
1998. The incidence of multidrug-resistant TB
decreased by 91% over the same period (4).
In the United Kingdom, TB rates began to
increase in 1988 but have since leveled off (5),
except in London, where the increase has been
much more dramatic and has not subsided (6).
This article compares the current epidemiology
and control of TB in London with the situation
in New York City in the late 1980s. Urgent
action is needed to strengthen TB control in
London if an epidemic like that in New York
City is to be avoided.
Epidemiology of TB in the Two Cities
The increase in TB notifications in London is
similar to that seen during the first 10 years of
the epidemic in New York City (Figure) (7). As in
New York, rates of disease differ considerably in
different parts of the city, with the highest rates
in areas of low socioeconomic conditions and
large immigrant populations (2,3,6). In New
York, the highest rates were in central Harlem
(79 per 100,000 in 1980 to 170 in 1989) (2). In
London, the highest rates are in Newham, Tower
Hamlets, and Brent (77-79 per 100,000 population)
(6). Rates in several London boroughs have
increased two- to threefold in 10 years (6). In
both cities, the increase in case reports has
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Figure. Tuberculosis rates in London, 1982–1997,
compared with those in New York, 1972–1994.13 13 13 13 13 Vol. 6, No. 1, January–February 2000 Emerging Infectious Diseases
Perspectives Perspectives Perspectives Perspectives Perspectives
been mainly among young adults (15-24 years
of age)         (3,6).
In both cities, most cases are in nonwhite
residents. In New York City in 1994, 50% of TB
patients were classified as black, non-Hispanic;
26% as Hispanic; 12% as white, non-Hispanic;
and 12% as other/unknown (8). In London
in 1993, 40% were classified under Indian
Subcontinent, 31% white, and 29% “other
nonwhite” (9). From 1988 to 1993, London rates
increased most in the “other nonwhite” category
(mainly black Africans) but also increased among
whites and nonwhites who were born in the
United Kingdom. (The rate among those of
Indian Subcontinent background who were born
in the United Kingdom rose from 12 per 100,000
in 1988 to 41 per 100,000 in 1993 [9]). Therefore,
importation of disease is not the only factor
causing the increase in London.
In London (as in New York at the beginning
of the epidemic), data on patient origins are not
routinely collected. Preliminary data suggest
that at least 55% of cases are among foreign-
born persons (H. Maguire, pers. comm.). In
New York in 1993-94, approximately 28% of TB
cases were among immigrants (3). Thus, in
both cities a substantial proportion of cases is
among immigrants, but this disparity is
greater in London.
Early in the epidemic in New York, 38% of
persons with culture-confirmed cases of TB were
known to be HIV infected (2). Data on HIV
infection in TB patients are not routinely
collected in the United Kingdom, but a study in
1993 estimated that at least 7% of TB cases in
London were among HIV-positive persons (10). A
more recent study of 157 patients starting
treatment for TB at an inner-city London
hospital in 1996 and 1997 showed that 25% were
coinfected with HIV (44% Europeans, 49%
Africans, and 3% Asians). These data suggest
that, in some ethnic groups in some areas of
London, HIV infection is strongly affecting the
epidemiology of TB (11).
Data on drug resistance were not routinely
collected early in the epidemic in New York City.
In the early 1990s, 19% of patients with culture-
confirmed TB had multidrug-resistant TB, and
in 26% of patients TB was resistant to isoniazid
(12). These figures had declined to 4.1% and 4.4%
by 1998 (4). In 1994-96, 2.6% of isolates in
London were multidrug resistant, compared
with 1% in the rest of the country; 8% were
resistant to isoniazid, compared with 4.7% in the
rest of the country (13). The current levels of
drug resistance in London are lower than those
during the epidemic in New York. However, data
from New York demonstrate that transmission of
resistant strains in hospitals and other settings
can lead to a rapid increase in rates of resistance
(14). Several outbreaks of TB, including two
involving multidrug-resistant TB, have already
occurred in London, principally affecting HIV-
positive patients in teaching hospitals (15-17).
Recent transmission appears to be a
substantial problem in both cities. Preliminary
results from a molecular study to identify recent
transmission of TB in inner London suggest that
approximately 27% of cases are clustered (10). In
New York City, an analysis of the molecular
epidemiologic links of TB isolates obtained in
April 1991         showed that, of 344 patients, 126 (37%)
belonged to one of 31 clusters, and clustering was
more frequent in patients who had multidrug-
resistant TB (involved in 53% of clusters), were
black (44%), and were homeless (49%) (14).
Both London and New York City have large
populations of homeless people (86,000 in New
York in 1990 compared with 50,000 in London in
1992) (18,19). In New York City in the 1970s and
1980s, approximately 6% to 7% of homeless persons
had active TB (20,21). By 1992, up to 25% of the
city’s cases of TB occurred in the homeless (22).
Fewer data are available for TB rates in London’s
homeless, but information suggests very high
levels of TB. Screening at a shelter in London in
1993 identified active TB in 1.5% of those screened.
Another 3.5% had chest X-rays suggestive of active
disease, but the patients were lost to follow-up
before further investigation could take place
(23). At least 5% of TB patients in London have a
history of residence in a hostel for the homeless (H.
Maguire, pers. comm.). In both cities, poor
compliance with treatment and transmission of
disease are major problems in the homeless (18,21).
TB transmission in state correctional
facilities was a major problem in New York (3).
No outbreaks of TB have yet been documented in
prisons in London.
Control in London and New York City
The loss of government funding of TB
programs in the 1970s and 1980s in New York
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poorer sectors of the population (often nonwhite
patients) (3), likely contributing to increases in
disease in these groups. In the United Kingdom,
all patients have free access to National Health
Service treatment, but new immigrants, asylum
seekers, refugees, and illegal immigrants may
have difficulty accessing health services because
of cultural and linguistic barriers (24). Some may
have difficulty in obtaining free prescriptions
because of lack of necessary documents (24). In
addition, immigration policies differ: in the
United States, immigrants are screened and
treated for active disease before entering the
country, and skin-test-positive new entrants are
usually treated for latent infection (25). In the
United Kingdom, a few entrants are screened at
airports, with the rest being screened at the local
level. In some areas, only a few new entrants are
screened, and chemoprophylaxis is rarely used
except in children (24,26). Thus, disease preva-
lence among nonwhite patients may be related to
inadequate screening in the United Kingdom.
Treatment completion rates in some areas of
New York were low. In 1989, for example, 40% of
patients with TB did not complete treatment in
the city (27), and in some locales, up to 90% of
patients did not complete treatment (2). Early in
the epidemic, directly observed therapy was
rarely used. In London, the number of patients
who complete treatment is not known, and
directly observed therapy is rarely used (24). An
audit in a London hospital showed that 19% of
patients were lost to follow-up before completing
treatment. In another 15%, patient records were
unavailable (A. Pearson, pers. comm.). A study of
TB among the homeless in London found that
43% of suspected cases were lost to follow-up
even before the diagnosis could be confirmed
(23). Currently, treatment completion rates are
not routinely monitored in London.
In the United Kingdom, section 37 of the
Public Health (Control of Disease) Act of 1984
allows detention of patients who pose a serious
risk for infection to others. In contrast to New
York City, where coercion was considered by
many to be an important element of TB control
(28), this power is rarely used in London (24).
Use of detention is difficult to justify when the
infrastructure to allow less coercive adherence-
support methods (such as directly observed
therapy) is not in place (29). Increasing use of
incentives and flexible provision of directly
observed therapy in New York City has greatly
decreased the use of detention (28). Directly
observed therapy to improve compliance is rarely
used in London, and for the least compliant
patients it is almost impossible to provide (24).
Early in the epidemic in New York, there
were insufficient measures to prevent spread of
TB in hospitals, but by 1997 the city had 400
negative-pressure isolation facilities (30). In 1995
in London, there were 103 negative-pressure
isolation facilities, only 17 of which had continuous
air-pressure monitoring and 49 were considered
adequate for housing patients with infectious
multidrug-resistant TB (A. Hayward, unpub.
obs.). Guidelines have recently been published to
improve infection control in hospitals (31), but
adherence will be difficult without an increase in
the availability of isolation facilities.
Inappropriate treatment of isoniazid-resis-
tant patients (e.g., failing to use an initial
regimen including at least four drugs) is thought
to have contributed to the development of
multidrug-resistant TB in New York (12), but the
explosive rise in rates of multidrug-resistant
disease was mainly due to transmission of
disease among hospitalized HIV-infected pa-
tients (14). It is not known what proportion of
patients in London are initially treated with a
four-drug regimen. The high rates of isoniazid
resistance in London indicate the potential for
rates of multidrug-resistant TB to increase if
such regimens are not used. Hospital transmis-
sion could then lead to further rapid increases.
At the beginning of the epidemic in New
York, surveillance did not provide routine data
on drug resistance, ethnicity, country of origin,
HIV-related TB, or treatment completion rates.
The lack of information delayed recognition of
the problem, and assumptions that TB was an
immigrant problem proved not to be accurate
(32). Similarly, surveillance in London has failed
to collect routine data. Drug resistance levels
have been monitored routinely only since 1994,
and information (such as knowledge of previous
treatment) that would be of value in interpreting
routine data is often not available. An enhanced
surveillance system has been launched in the
United Kingdom, but many London districts are
having difficulties in obtaining the additional
information required (24). The new system does
not currently collect data on treatment
completion rates, but collecting such data is15 15 15 15 15 Vol. 6, No. 1, January–February 2000 Emerging Infectious Diseases
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proposed for the next stage of development
(J. Watson, pers. comm.).
During the early part of the TB epidemic in
New York City, TB control was underfunded and
highly fragmented (3). Underfunding of TB
services is also a major barrier to improving TB
control in London (24), and the system is also
highly fragmented (24). For example, in London
in 1993, TB was treated by 250 doctors working
in 45 different hospitals (5). In the United
Kingdom, district-based “Consultants in Com-
municable Disease Control” are responsible for
control of TB and other infectious diseases in the
community. Unlike TB coordinators in the
United States, they have no direct authority to
design treatment programs or institute directly
observed therapy.
Conclusions
The epidemiology and control of TB in
London now differ in several ways from those in
New York City early in the epidemic: London has
a lower proportion of cases in HIV-infected
patients, a higher proportion of cases among
immigrants, and lower levels of multidrug
resistance. However, similarities in epidemiol-
ogy and control include similar numbers of cases;
a similar increase in disease prevalence; very
high prevalence in areas of lower socioeconomic
conditions and large ethnic populations; concen-
trations of disease in the homeless, the HIV
infected, and immigrants; transmission of
multidrug-resistant strains in hospitals; inad-
equate isolation facilities; unknown treatment
completion rates; high levels of loss to follow-up;
and no overall coordination among providers of
TB services. All these factors suggest that if TB
control in London is not improved, the city could
experience an epidemic of similar proportions to
that in New York.
Although need for action was recognized in
New York City in 1987, a clear plan for action
was not implemented until 1992. By 1995, the
epidemic had cost more than $1 billion (3).
London needs to learn from the New York
epidemic and take prompt action to improve
control by developing solutions based on the local
epidemiology of the disease.
Acknowledgment
This study was conducted at the Public Health
Laboratory Service, Communicable Disease Surveillance
Centre, London Region, United Kingdom.
Dr. Hayward is a Lecturer in Public Health and
Epidemiology at the University of Nottingham. His re-
search interests are the epidemiology and control of in-
fectious diseases, particularly tuberculosis.
Dr. Coker is affiliated with the Imperial College
School of Science, Technology and Medicine in London
as a Senior Lecturer. His book, “From Chaos to Coer-
cion: Detention and the Control of Tuberculosis,” is to
be published in January 2000, by St. Martin’s Press of
New York.
References
    1. World Health Organization. Tuberculosis—a global
emergency. WHO report on the TB epidemic. Geneva:  The
Organization; 1994.
  2. Brudney K, Dobkin J. Resurgent tuberculosis in New York
City: human immunodeficiency virus, homelessness and
the decline of tuberculosis control programs. American
Review of Respiratory Disease 1991;144:745-9.
  3. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA.
Tuberculosis in New York City—turning the tide. N
Engl J Med 1995;333:229-33.
  4. Bureau of Tuberculosis Control Information Summary
1998. New York: New York City Department of
Health; 1999.
  5. Hayward AC, Watson JM. Tuberculosis in England and
Wales 1982-1993: notifications exceeded predictions.
Commun Dis Rep Wkly 1995;5:RR29-33.
  6. Hayward A. Tuberculosis control in London: the need
for change. London: NHS Executive; 1998.
  7. Tuberculosis in New York City, 1988. New York: New
York City Department of Health; 1990.
    8. Information summary. New York City: Bureau of
Tuberculosis Control, New York City Department of
Health, 1995.
  9. Ormerod LP, Charlett A, Gilham C, Darbyshire JH,
Watson JM. Geographical distribution of tuberculosis
in national surveys of England and Wales in 1998 and
1993: report of the Public Health Laboratory Service,
British Thoracic Society, Department of Health
Collaborative Group. Thorax 1998;53:176-81.
10. Hayward AC, Goss S, Drobniewski F, Saunders N,
Goyal M, Shaw R, et al. Molecular epidemiology of
tuberculosis in London. British Thoracic Society Winter
Conference, December 1997.
11. Marshall BG, Mitchell DM, Shaw RJ, Marais F, Watkins
RM, Coker RJ. HIV and tuberculosis coinfection in an inner
London Hospital—a prospective anonymized
seroprevalence study. Journal of Infection        1999:38:162-6.
12. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn
JO, Cauthen GM, Dooley SW. The emergence of drug-
resistant tuberculosis in New York City. N Engl J
Med 1993;328:521-6.
13. Irish C, Herbert J, Bennett D, Gilham C, Drobniewski
F, Williams R, et al. Database study of antibiotic
resistant tuberculosis in the United Kingdom, 1994-6.
BMJ 1999;318:497-8.
14. Frieden TR, Woodley CL, Crawford JT, Lew D, Dooley
SM. The molecular epidemiology of tuberculosis in New
York City: the importance of nosocomial transmission
and laboratory error. Tuber Lung Dis 1996;77:407-13.16 16 16 16 16 Emerging Infectious Diseases Vol. 6, No. 1, January–February 2000
Perspectives Perspectives Perspectives Perspectives Perspectives
15. Outbreak of hospital acquired multidrug-resistant
tuberculosis. Commun Dis Rep CDR Wkly 1994;4:1.
16. Breathnach AS, de Ruiter A, Holdsworth GM, Bateman
NT, O’Sullivan DG, Rees PJ, et al. An outbreak of
multidrug resistant tuberculosis in a London teaching
hospital. J Hosp Infect 1998;39:111-7.
17. Kent PJ, Uttley AHC, Stoker NG, Miller R, Pozniak AL.
Transmission of tuberculosis in British centres         for
patients infected with HIV. BMJ 1994;309:639-40.
18. Citron KM, Southern A, Dixon M. Out of the shadow.
London: CRISIS; 1995.
19. Dugger CW. Study says shelter turnover hides scope
of homelessness. The New York Times; 1993
November 16:A1.
20. Sherman MN, Brickner MS, Schwartz MS. Tuberculosis in
single-room occupancy hotel residents: a persisting focus of
disease. New York Medical Journal 1980;2:39-41.
21. McAdam JM, Brickner PW, Scharer LL, Crocco JA, Duff
AE. The spectrum of tuberculosis in a New York City men’s
shelter clinic (1982-1988). Chest 1990;97:798-805.
22. Tuberculosis in New York City, 1992. New York City:
New York City Department of Health; 1992.
23. Kumar D, Citron KM, Leese J, Watson JM. Tuberculosis
among the homeless at a temporary shelter in London:
report of a chest X-ray screening programme. J Epidemiol
Community Health 1995;49:629-33.
24. Results of pan London multidisciplinary workshops on
tuberculosis control. Report to the Director of Public
Health for London; 1999.
25. American Thoracic Society. Control of tuberculosis in the
United States. Am Rev Respir Dis 1992;146:1623-33.
26. Hardie RM, Watson JM. Screening immigrants at risk
of tuberculosis. BMJ 1993;307:1539-40.
27. Tuberculosis. City Health Information (CHI) 1996;15:12-3.
28. Gasner MR, Maw KL, Feldman GE, Fujiwara PI,
Frieden TR. The use of legal action in New York City to
ensure treatment of tuberculosis. N Engl J Med
1999;340:359-66.
29. Coker RJ. Public health, civil liberties, and tuberculosis.
BMJ 1999;318:1434-5.
30. Perales, CA. Memorandum to Mayor David N. Dinkins.
Update on tuberculosis control activities. New York:
Office of the Mayor; 1998.
31. The Interdepartmental Working Group on Tuberculosis.
The prevention and control of tuberculosis in the United
Kingdom. Prevention of transmission of drug resistant
tuberculosis and tuberculosis in HIV infected patients.
London: Her Majesty’s Stationery Office;  ;  ;  ;  ; 1999.
32. Bellin E. Failure of tuberculosis control: a prescription
for change. JAMA 1994;271:708-9.